Guangxi LiuYao Group Co., Ltd (SHA:603368)
China · Delayed Price · Currency is CNY 15.77
+0.13 (0.83%)
Jul 31, 2026, 3:00 PM CST
Guangxi LiuYao Group Market Cap
Guangxi LiuYao Group has a market cap or net worth of 5.36 billion as of July 31, 2026. Its market cap has decreased by -26.33% in one year.
Market Cap
5.36B
Enterprise Value
7.92B
Revenue
20.99B
Ranking
n/a
PE Ratio
9.25
Stock Price
15.77
ChartMarket Cap Chart
Since December 4, 2014, Guangxi LiuYao Group's market cap has increased from 4.25B to 5.36B, an increase of 26.20%. That is a compound annual growth rate of 2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.36B | -22.68% |
| Dec 31, 2025 | 6.93B | -2.61% |
| Dec 31, 2024 | 7.12B | 4.58% |
| Dec 29, 2023 | 6.81B | 0.66% |
| Dec 30, 2022 | 6.76B | -1.81% |
| Dec 31, 2021 | 6.89B | -11.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 55.82B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 34.24B |
| Jointown Pharmaceutical Group | 25.53B |
| China National Medicines Corporation | 21.22B |
| Liaoning Cheng Da | 16.64B |
| China Meheco Group | 14.26B |
| China National Accord Medicines Corporation | 12.02B |
| Qingdao Baheal Medical INC. | 11.77B |